Chronic high-dose use may not be wise for someone with cardiovascular disease risk, high LDL cholesterol, kidney disease, or a medical history that already warrants monitoring
One implication of this requirement is that mechanisms of homeostatic synaptic scaling, which induce plastic changes after many hours or days of dramatic alterations of activity level (Watt and Desai, 2010
GLP-1 receptor agonists, such as Semaglutide, are FDA-approved prescription medications that play a crucial role in regulating food intake, controlling blood sugar levels, and enhancing feelings of fullness
Mechanism of JAK2 Activation by the GHR Recent studies have made major strides in elucidating the mechanism of JAK2 activation by GHR (84)
Discussing this with biotech/pharma sponsors and building some dose escalation buffer into a protocol to keep the participant in the study and manage these AEs (when possible) can be a good strategy to keep participants in the trial & improve their experience
doi: 10.1016/j.taap.2020.115272 53 ChiomaOSDrakeWP
